Riskpilot← Back to searchSign inGet full accessSupramed AB
ABActiveOrg 5567955272Hästholmsvägen 28 2trMedical specialists activities · NACE 8622Est. 20092 employees
Revenue 2025
SEK 4,1M
-11% vs 2024
EBITDA margin
-4.4%
-168% vs 2024
Equity ratio
9.9%
Financial strength
Net profit 2025
SEK -249K
-422% vs 2024
| Revenue | SEK 4,1M | -11% |
| EBITDA | SEK -181K | -168% |
| Net profit | SEK -249K | -422% |
| Total assets | SEK 889K | -33% |
| Equity | SEK 88K | -68% |
| Employees | 2 | — |
Legal name
Supramed AB
Org number
5567955272
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 december 2009
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva mottagningsverksamhet inom hälso- och sjukvård och annan verksamhet inom medicinska området jämte därmed förenlig verksamhet. Bolaget kan också bedriva medicinkonsultuppdrag såsom forskning, utbildning, rådgivning och försäljning av medicinska och kosmetiska varor och även bemanningsuppdrag inom hälso- och sjukvården. Vidare skall bolaget bedriva handel med värdepapper och förvaltning av fastigheter samt därmed förenlig verksamhet.
Address
Hästholmsvägen 28 2tr
Email
susanne@supramed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 524 | 2 665 | 3 143 | 2 918 | 3 225 | 3 987 | 4 601 | 4 091 |
| Staff expenses | — | — | — | — | — | — | −2 605 | −2 392 | −2 953 | −2 586 |
| EBITDA | 57 | −47 | −998 | −200 | 347 | −330 | −668 | 79 | 267 | −181 |
| Depreciation & amort. | −17 | −22 | −22 | −22 | −22 | −24 | −28 | −21 | −35 | −28 |
| EBIT | 40 | −69 | −1 020 | −222 | 325 | −354 | −697 | 58 | 232 | −210 |
| Net financials | 294 | 3 950 | 1 | −9 | −6 | −5 | −49 | −26 | −155 | −39 |
| Profit before tax | 334 | 3 882 | −1 018 | −230 | 319 | −358 | −746 | 32 | 77 | −249 |
| Tax | −16 | −1 | −0 | −0 | −0 | −0 | — | — | — | — |
| Net profit | 318 | 3 881 | −1 018 | −230 | 319 | −358 | −746 | 32 | 77 | −249 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 952 | 4 610 | 925 | 822 | 1 039 | 846 | 1 005 | 1 151 | 1 336 | 889 |
| Equity | 419 | 4 299 | 662 | 582 | 901 | 543 | 162 | 195 | 272 | 88 |
| Long-term debt | 0 | 0 | 0 | 91 | 0 | 131 | 517 | 668 | 790 | 579 |
| Short-term debt | 533 | 311 | 263 | 149 | 138 | 172 | 325 | 288 | 274 | 223 |
| Total debt | 533 | 311 | 263 | 240 | 138 | 303 | 842 | 957 | 1 064 | 801 |
EBITDA margin
-4.4%
This company
15.8%
Market median
-128% vs market
20162025
Equity ratio
9.9%
This company
38.2%
Market median
-74% vs market
20162025
Return on equity
-282.4%
This company
18.4%
Market median
-1635% vs market
20162025
Net profit margin
-6.1%
This company
8.1%
Market median
-175% vs market
20162025
Asset turnover
4.60×
This company
1.12×
Market median
+311% vs market
20162025
Debt / equity
9.10×
This company
0.62×
Market median
-1368% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Åhnblad Holding AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Åhnblad Holding AB
Supramed AB Board members of Supramed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Michael Georg Åhnblad | Chief Executive Officer | 0 companies |
| Maria Susanne Lagerkvist Åhnblad | Deputy Board Member | 0 companies |